- Home/In The News/Blog/2013/September
30
September2013
category:
503b CompoundingH.R. 3204 – 42% chance of being enacted
Status This bill passed in the House on September 28, 2013 and goes to the Senate next for consideration. Progress Introduced Sep 27, 2013 Referred to Committee Sep 27, 2013 Passed House Sep 28, 2013 Passed Senate … Signed by the President … Prognosis 42% chance of being enacted.https://www.govtrack.us/congress/bills/113/hr3204
read more30
September2013
category:
503b CompoundingBGOV Bill Summary: H.R. 3204, Drug Compounding and Supply Safety
(Bloomberg) — The Food and Drug Administration’s oversight of compounded drugs would be expanded and the U.S. for the first time would have uniform standards to monitor drug distribution from factories to pharmacies under H.R. 3204. The bill, which reflects an informal House-Senate agreement on the issues, would allow the FDA to collect and spend […]
read more30
September2013
category:
503b CompoundingUse of Propofol In Executions Could Result In Anesthetic Shortage, EU Sanctions
The state of Missouri plans to execute a death row inmate next month using for the first time a lethal dose of the widely-used anesthesia drug propofol. The European Union (EU), where most of the U.S. propofol supply is manufactured and capital punishment is banned, is warning that export sanctions may be imposed on the […]
read more